GlobalData Conferences Presents: Embracing Disruption in Pharma: Is COVID-19 a Catalyst for Lasting Change?

COVID-19 has been a wake-up call for the biopharmaceutical industry to innovate, rethink its operations, and adopt new ways of working in order to harness relationships with customers, regulators, and investors. During the pandemic, the industry has shown its resilience and ability to adapt at an accelerated pace if needed. Technologies that were at early stages of implementation have been swiftly adopted to allow business continuity and minimize disruption, such as artificial intelligence and virtual trials.This two-hour twenty-minute virtual conference brings together the very best insight and gold-standard intelligence from GlobalData’s Pharma practice to provide an outlook for the biopharmaceutical industry. With a comprehensive agenda covering industry trends and emerging technologies, this conference will enable you to see how your business fits into the bigger picture.

Aimed at those keen to understand global trends and industry themes, our virtual conference will help you to:

• See what industry themes have come to the forefront since the start of the pandemic, such as genomics with mRNA-based COVID-19 vaccines, as well as pharma outsourcing with contract manufacturing agreements
• Understand what emerging technologies pharma companies are currently investing in, and which are expected to disrupt the industry in the near future
• Gain insight from ‘alternative’ data sets, including company filings and hiring trends, to understand which industry players are tuned into the most important themes set to impact the pharma industry over the coming year

Intended Audience:

• Brand & Product Managers
• Strategy Planners and Directors
• Global & Regional Marketing Directors
• Insight Managers and Directors

Sectors Covered:

• Overview of the impact of the COVID-19 pandemic on the pharma industry
• Coverage of mRNA-based drugs
• Key themes and technologies for 2022
• Virtual trials
• Pharma outsourcing

Agenda

Welcome & Introduction – 15 mins

Before we launch into the conference proper, Dr Bonnie Bain, Global Head and EVP of Healthcare Operations and Strategy, will be giving a brief introduction into just how the global pandemic forced a seismic shift across many aspects of the pharma industry.

Forecasts & Prospects – 30 mins

Tina Healy MSc, Vice President of Disease Analysis and Intelligence, and Dr Michael Breen, Director of Infectious Diseases, will be examining how COVID-19 has accelerated the development and use of mRNA vaccines, discussing sales forecasts and future expectations for mRNA-based drugs, and evaluating who the leaders are in this space.

Industry Insights – 30 mins

Urte Jakimaviciute MSc, Senior Director of Market Research, and Kitty Whitney MSc, Director of Pharma Thematic Analysis, will be running through the key themes and technologies expected to impact the pharma industry in 2022, including virtual care. Gain insight into how the industry is building digital transformation roadmaps, what trends, opportunities, and challenges it continues to face in the wake of COVID-19, and which emerging technologies companies are prioritizing for current and future investments. There will also be a top line view of the outsourcing landscape in light of the pandemic.

Thematic Analysis –20 mins

Dr Lil Read from the GlobalData Thematic Analysis team will be taking you through the alternative datasets which lie brimming with market information to those with the power to see it. From company filings and deals, unpick the themes set to disrupt the pharma value chain. She will also be identifying which players are tapping into these wave-making themes with success, and which aren’t – listing the winners and losers in this exciting space, as well as any key plays being made.

Future Products & Services – 25 mins

Scotty Chung-Siu, Senior Analyst for GlobalData’s Trials Intelligence, will delve deeper into the virtual trials sector, which has seen unprecedented growth over the past two years. Get an overview of which companies are implementing the highest number of trials with virtual components and see what technologies you can use to bring research closer to patients and improve trial diversity.

Then Dr Peter Shapiro, Senior Director of Drugs Database and Platform Integration, will provide deeper insights into the changing landscape of pharma outsourcing, particularly how it was impacted by the pandemic with a focus on contract manufacturing of vaccines, as well as the importance of key players such as India and China. See who the big names are in the contract manufacturing space offering their services in vaccine and other complex drugs.

Conclusions & Outlook – 10 mins

In this penultimate segment, our panel will be drawing together their research to provide insights on the future of the biopharmaceutical industry.

What is the market outlook now? What themes and forces are poised to have the most impact? Who are the players keying into the trends that will shape the market for the next decade? Acquire all the information you’ll need to go to market.

Q&A – 10 mins

Last, but not least, is the exclusive chance to field questions to our market-leading experts. For the last part of our conference, we’ll be opening the field to questions from the audience, as they apply to the topic at hand.

Bonnie Bain, Global Head and Executive Vice President of Healthcare Operations and Strategy

Dr Bonnie Bain has over 20 years’ experience in the healthcare sector and a proven track record of developing innovative solutions on both the client and agency sides of the business. Under her leadership, GlobalData have launched a number of premium syndicated reports, analytical tools and databases in the pharmaceuticals and medical devices space.

Prior to joining GlobalData, Bonnie was Vice President and Global Research & Analysis Director for Informa’s Pharma Division, which includes Datamonitor Healthcare, Scrip Group, and Business Insight.

Michael Breen, Director of Infectious Diseases and Ophthalmology

Michael Breen, PhD, is the Director of Infectious Diseases and Ophthalmology at GlobalData in Boston. He has over eight years of experience in market analysis, business intelligence, and providing strategic insight for the pharmaceutical industry. Prior to his current role, he was a Senior Analyst for Decision Resources Group, where he gained extensive experience writing in-depth reports and developing forecasts for a variety of indications, including rare and infectious diseases and vaccines.

Michael has a BA in biology and biochemistry from Hunter College, and a PhD in biochemistry from Boston University School of Medicine.

Scotty Chung-Siu, Senior Analyst, Trials Intelligence

Scotty Chung-Siu, MPH, BS, is a Senior Analyst at GlobalData in Atlanta, Georgia, responsible for producing analytical reports, updating database updates for major drug indications, maintaining and improving database functionality through quality assurance testing, and providing customer service through client queries. Prior to joining GlobalData, Scotty worked as the Research Analyst at PharmSource researching biotechnology, medical technology, and pharmaceutical product development information.

Scotty holds a Master of Public Health with a concentration in Environmental Health from Eastern Virginia Medical School and a Bachelor of Science in Biology from George Mason University.

Urte Jakimaviciute, Senior Director of Market Research

Urte Jakimaviciute, MSc, is Senior Director of Market Research in the healthcare division of GlobalData, London, with more than 10 years of experience in the market research industry. Her primary responsibility includes managing the market research process for the syndicated portfolio, thematic reports, and custom consulting projects.

Lil Read, Analyst, Thematic Research

Dr Lil Read is an Analyst in GlobalData’s Thematic Research team, which she joined in October 2020 after completing her PhD at the University of Cambridge. In her role she has covered the themes making the largest impact across the world of business, assisting in the syndicated research process on topics such as AI, ESG, and IoT. Her areas of specialist interest include semiconductors and social media.

Peter Shapiro, Senior Director of Drugs Database and Platform Integration

Peter Shapiro, PhD, is Senior Director of the Drugs and Platform Integration in the Data Intelligence and Solutions team and also serves as the Editor-in-Chief of PharmSource. Peter previously worked on the integration of BioPharm Insight, Lead Sheet, and PharmSource into GlobalData’s Pharma Intelligence Center.

Peter holds a PhD in Molecular and Cellular Biology from the Vilcek Institute of New York University and is located in GlobalData’s office in New York City.

Carrie Salter, Head of Customer Success in America

GlobalData is committed to ensuring that your business maximizes the best return on your investment in our intelligence services. This will be delivered through our unrivaled Customer Success ecosystem. We are here to provide you: On-site support and self-service offering instant solutions Product Tours help you get to grips with new and existing features Notifications keep you informed of the latest releases Help Center contains key support guides, recommendations and top tips Ask an Analyst at any time if you need fast assistance with a query Training Calls & Webinars offer interactive, insight-led sessions on your industry sector.

Kitty Whitney, Director of Pharma Thematic Analysis

Kitty Whitney, MSc, is the Director of Thematic Analysis in the pharma division of GlobalData, London, where she is responsible for delivering all research projects within the space. Her pharmaceutical industry knowledge is comprehensive, gained from her time working within Healthcare at Home’s business strategic group, and during her time in analysis positions at Intelligentsia Worldwide and IMS Health.